Virax Biolabs

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Virax Biolabs and other ETFs, options, and stocks.

About VRAX

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom. 

CEO
James Foster
CEOJames Foster
Employees
26
Employees26
Headquarters
Lanarkshire, Scotland
HeadquartersLanarkshire, Scotland
Founded
2013
Founded2013
Employees
26
Employees26

VRAX Key Statistics

Market cap
449.19K
Market cap449.19K
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
—
Dividend yield—
Average volume
207.40K
Average volume207.40K
High today
$0.37
High today$0.37
Low today
$0.3287
Low today$0.3287
Open price
$0.3696
Open price$0.3696
Volume
85.89K
Volume85.89K
52 Week high
$21.75
52 Week high$21.75
52 Week low
$0.2928
52 Week low$0.2928

Stock Snapshot

As of today, Virax Biolabs(VRAX) shares are valued at $0.37. The company's market cap stands at 449.19K, with a P/E ratio of -0.02.

On 2026-11-22, Virax Biolabs(VRAX) stock moved within a range of $0.33 to $0.37. With shares now at $0.37, the stock is trading +12.6% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 85.89K, compared to an average daily volume of 207.4K.

Over the past 52 weeks, Virax Biolabs(VRAX) stock has traded between a high of $21.75 and a low of $0.29.

Over the past 52 weeks, Virax Biolabs(VRAX) stock has traded between a high of $21.75 and a low of $0.29.

VRAX News

Simply Wall St 3d
Virax Biolabs Group (Nasdaq:VRAX) - Stock Analysis - Simply Wall St

...

Virax Biolabs Group (Nasdaq:VRAX) - Stock Analysis - Simply Wall St
TipRanks 4d
Virax Biolabs Group Published Updated Q4 2026 Investor Presentation

Virax Biolabs Group Ltd. Class A ( (VRAX) ) has shared an announcement. Virax Biolabs Group Limited is identified as a foreign private issuer with principal ex...

People also own

Based on the portfolios of people who own VRAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.